ClinicalTrials.Veeva

Menu

Defocused Shock Wave Therapy for Chronic Wounds

U

University of Roma La Sapienza

Status and phase

Completed
Phase 3

Conditions

Wounds

Treatments

Device: Defocused shock wave therapy (DUOLITH® SD1)

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Chronic soft tissue wounds of the lower limbs are painful and debilitating condition that significantly reduce the quality of life of the patient. They often do not respond to conservative treatments or advanced wound managements. Focused and defocused extracorporeal shock wave therapy can be a viable alternative therapeutic strategy.

The purpose of the study was to examine the effects of defocused extracorporeal shock wave treatment on chronic soft tissue wounds of the lower limbs, in terms of the rate of wound healing and pain control.

Enrollment

10 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • chronic post-traumatic, venous, arterial, diabetic, or mixed wound of the lower limb
  • wound persisting for longer than three months
  • a wound surface bigger than 0,5 cm2
  • a wound diameter between 0.5 and 5 cm
  • unresponsiveness to conservative treatments and advanced wound managements in the 3 months prior to enrollment
  • no changes in wound managements during the study.

Exclusion criteria

  • an ankle brachial index (ABPI)<0.7 and TcPO2<40 mmHg
  • arrhythmias, presence of pacemaker, or coagulation disorders
  • use of anticoagulant drugs
  • neoplasia
  • pregnancy
  • soft tissue wound infections and/or osteomyelitis
  • patients with full-thickness loss of soft tissue and extension into muscle, bone, tendon, or joint capsule.

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

10 participants in 1 patient group

Treatment Group
Experimental group
Description:
Defocused shock waves were provided by an electromagnetic generator (DUOLITH® SD1 - Storz Medical AG, Tägerwilen, Switzerland). The protocol consisted of a series of 3 sessions in 2 weeks, 2 treatments a week. For each patient, a different number of impulses per session was delivered, depending on wound size (300 impulses + 100 impulses per cm2 wound-surface), at an energy flux density of 0.15 mJ/mm2 and a frequency of 5 pulses/s.
Treatment:
Device: Defocused shock wave therapy (DUOLITH® SD1)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems